title: Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists.
authors.forename: Laure
authors.initials: L
authors.lastname: Brulhart
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Nissen
authors.forename: Paola
authors.initials: P
authors.lastname: Chevallier
authors.forename: Cem
authors.initials: C
authors.lastname: Gabay
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001799:Blood Sedimentation; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D004361:Drug Tolerance; D015796:HLA-B27 Antigen / Q000145:classification / Q000235:genetics; D006801:Humans; D007596:Joints / Q000473:pathology / Q000503:physiopathology; D008297:Male; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy / Q000235:genetics; D016059:Range of Motion, Articular; D012720:Severity of Illness Index; D013167:Spondylitis, Ankylosing / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014605:Uveitis / Q000150:complications / Q000188:drug therapy / Q000235:genetics
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D015796:HLA-B27 Antigen; D014409:Tumor Necrosis Factor-alpha; C502936:tocilizumab